Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
  • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
  • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
  • A61P25/16—Anti-Parkinson drugs
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/24—Antidepressants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
  • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
  • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
  • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
  • C07D491/04—Ortho-condensed systems
  • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
  • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
  • C07D491/04—Ortho-condensed systems
  • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
  • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered

Applications Claiming Priority (2)

Publications (1)

Family

ID=52779655

Family Applications (1)

Country Status (38)

Families Citing this family (4)

Family Cites Families (18)

• 2015
  • 2015-03-27 AP AP2016009521A patent/AP2016009521A0/en unknown
  • 2015-03-27 US US15/301,210 patent/US10005764B2/en active Active
  • 2015-03-27 AU AU2015239696A patent/AU2015239696B2/en not_active Ceased
  • 2015-03-27 JP JP2016560728A patent/JP6554116B2/en active Active
  • 2015-03-27 RU RU2016138743A patent/RU2692808C2/en active
  • 2015-03-27 PE PE2016001906A patent/PE20161380A1/en unknown
  • 2015-03-27 WO PCT/EP2015/056713 patent/WO2015150254A1/en active Application Filing
  • 2015-03-27 DK DK15713186.3T patent/DK3126354T3/en active
  • 2015-03-27 LT LTEP15713186.3T patent/LT3126354T/en unknown
  • 2015-03-27 SG SG11201608190YA patent/SG11201608190YA/en unknown
  • 2015-03-27 CR CR20160463A patent/CR20160463A/en unknown
  • 2015-03-27 GE GEAP201514286A patent/GEP20186920B/en unknown
  • 2015-03-27 CA CA2943011A patent/CA2943011A1/en not_active Abandoned
  • 2015-03-27 RS RS20200239A patent/RS60017B1/en unknown
  • 2015-03-27 SI SI201531112T patent/SI3126354T1/en unknown
  • 2015-03-27 CN CN201580017454.2A patent/CN106132953B/en active Active
  • 2015-03-27 EA EA201691773A patent/EA032579B1/en not_active IP Right Cessation
  • 2015-03-27 MA MA39837A patent/MA39837B1/en unknown
  • 2015-03-27 ES ES15713186T patent/ES2776359T3/en active Active
  • 2015-03-27 PL PL15713186T patent/PL3126354T3/en unknown
  • 2015-03-27 KR KR1020167027262A patent/KR20160138084A/en not_active Application Discontinuation
  • 2015-03-27 UA UAA201610191A patent/UA119166C2/en unknown
  • 2015-03-27 CN CN201910110735.2A patent/CN109999039A/en active Pending
  • 2015-03-27 MX MX2016012955A patent/MX364519B/en active IP Right Grant
  • 2015-03-27 PT PT157131863T patent/PT3126354T/en unknown
  • 2015-03-27 EP EP15713186.3A patent/EP3126354B1/en active Active
  • 2015-03-30 JO JOP/2015/0058A patent/JO3628B1/en active
  • 2015-03-31 TW TW104110439A patent/TWI664178B/en not_active IP Right Cessation
  • 2015-04-01 AR ARP150101009A patent/AR101155A1/en unknown
• 2016
  • 2016-09-22 ZA ZA2016/06566A patent/ZA201606566B/en unknown
  • 2016-09-27 DO DO2016000263A patent/DOP2016000263A/en unknown
  • 2016-09-27 IL IL248078A patent/IL248078B/en active IP Right Grant
  • 2016-09-29 PH PH12016501938A patent/PH12016501938A1/en unknown
  • 2016-10-03 GT GT201600213A patent/GT201600213A/en unknown
  • 2016-10-03 SV SV2016005297A patent/SV2016005297A/en unknown
  • 2016-10-03 CL CL2016002515A patent/CL2016002515A1/en unknown
  • 2016-10-20 EC ECIEPI201682599A patent/ECSP16082599A/en unknown
• 2018
  • 2018-06-13 US US16/007,561 patent/US10526319B2/en active Active
• 2020
  • 2020-03-04 CY CY20201100196T patent/CY1122784T1/en unknown
  • 2020-03-04 HR HRP20200369TT patent/HRP20200369T1/en unknown

Also Published As

Similar Documents